Berkenblit Anna 4
4 · ImmunoGen, Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Common Stock
2022-12-30$3.92/sh+436$1,709→ 110,671 total
Footnotes (2)
- [F1]These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July 1, 2022 through December 31, 2022
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022